
Dr. Elizabeth Bukusi’s Work on HIV Prevention and Care
To commemorate World AIDS Day held each year on December 1, we are highlighting Dr. Elizabeth Bukusi’s HIV research in Kenya! Dr. Bukusi is one of the foremost advocates for HIV care. She has conducted various studies in evaluating treatment options for high-risk populations. In one of her recent studies, she explored the value of post-exposure prophylaxis (PEP) and the antibiotic doxycylcine (dPEP) as an STI prevention strategy in African women taking PrEP, PrEP, or HIV pre-exposure prophylaxis, has been used over the past decade to prevent against HIV, however, there has also been a rising incidence of curable STIs in populations taking PrEP. The disproportionate risk that African women face from overlapping HIV-STI epidemics makes them an essential study population. dPEP is beneficial because it can be "woman-controlled," meaning that the effectiveness is not determined by partner participation, and that it's been shown to be safe for women. Dr. Bukusi predicts that dPEP will lead to a substantial reduction in the amount of...







